Tag: CORO
Risk for Myocarditis Low After BNT162b2 Booster in Israel
Risk estimates (cases per 100,000) 6.44 and 5.21 for males aged 16 to 19 and 20 to 24 years, respectively, compared with 1.42 overall
CDC Expert Panel OKs Omicron-Specific Boosters From Pfizer, Moderna
Hundreds of thousands of updated vaccine doses already being delivered around the country on Thursday
Risks for Neurologic, Psychiatric Sequelae Persist After COVID-19
Adults have increased risks for cognitive deficit, dementia, psychotic disorders, epilepsy or seizures at two-year follow-up
COVID-19 Vaccination in Pregnancy Not Tied to Adverse Birth Outcomes
No increased risk seen for overall preterm birth, spontaneous preterm birth, very preterm birth, SGA, or stillbirth
Parental Intent to Vaccinate Under 5s Against COVID-19 Examined
Odds of intending to vaccinate their children was lower for parents three months after a baseline survey versus baseline
FDA Approves Omicron-Specific Booster Shots From Pfizer, Moderna
Vaccine advisory panel for the CDC set to meet Thursday and Friday to discuss who should get the updated boosters
SARS-CoV-2 Infections Frequently Asymptomatic in Children
Infections most often asymptomatic for children aged 0 to 4 years; for adults, but not children, number of symptoms linked to viral load
SARS-CoV-2 mAbs Continued to Be Used After FDA Deauthorization
More than 158,000 doses of bamlanivimab-etesevimab and casirivimab-imdevimab were used after deauthorization on Jan. 24, 2022
Duration of Infectiousness Examined in COVID-19 Cases
65 and 24 percent of 34 cases continued to shed infectious virus at five and seven days after symptom onset
School-Aged Children Can Self-Swab for COVID-19 Testing
Close agreement seen between self-collected nasal swabs and swabs collected by health care workers for SARS-CoV-2 testing results
